|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| License and royalty revenue | |||||
| Minimum guaranteed royalties revenue (reversal of variable consideration) | |||||
| License revenue | |||||
| Royalty revenue | |||||
| Total revenues | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income: | |||||
| Interest and investment income | |||||
| Unrealized gain on warrant liability | |||||
| Total other income | |||||
| Income (loss) before income tax expense | |||||
| Income tax expense | |||||
| Net income (loss) | |||||
| Issuance of Series B preferred stock dividend | |||||
| Net unrealized gain (loss) on available-for-sale securities | |||||
| Comprehensive gain (loss) | |||||
| Basic income (loss) per share attributable to common stock | |||||
| Weighted average common shares outstanding, basic | |||||
| Diluted income (loss) per share attributable to common stock | |||||
| Weighted average common shares outstanding, diluted | |||||
Loading...